What are the top competitors of EssilorLuxottica S.A. in Healthcare sector?

The top competitors of EssilorLuxottica S.A. in the Healthcare sector are: Fresenius SE & Co. KGaA (FRE.SW), Edwards Lifesciences Corporation (EW.SW).

Which has better valuations & earnings, EssilorLuxottica S.A. or its competitors?

EssilorLuxottica S.A. has a market cap of 88.1B and a Dividend Yield of 1.91% compared to its competitors.

Which stock is more profitable: EssilorLuxottica S.A. or its competitors?

EssilorLuxottica S.A. has an EPS of CHF3.34, while FRE.SW has an EPS of CHF3.27. So, EssilorLuxottica S.A. is more profitable compared to FRE.SW.

What is EssilorLuxottica S.A. stock volatility and risk in terms of investment?

Volatility information is not available.

Is EssilorLuxottica S.A. stock profitable?

EssilorLuxottica S.A. has a Return on Equity (ROE) of 0.06%. So, EssilorLuxottica S.A. is more profitable.

What is EssilorLuxottica S.A. stock’s 52 weeks high and low?

EssilorLuxottica S.A. stock has a 52-week high of (CHF117) and a low of (CHF117).

What was the average volume of EssilorLuxottica S.A. stock?

The average volume of EssilorLuxottica S.A. is (1.6K) in terms of investment.

EssilorLuxottica S.A.

Get $10 bonus on your first $100 deposit for EI.SW

EI.SW•SIX

Healthcare

Medical - Specialties

Get $10 bonus on your first $100 deposit for EI.SW

CHF117.00

CHF0.00(0.00%)

Swiss Market is Open • 15:05

EssilorLuxottica S.A. (EI.SW) Stock Competitors & Peer Comparison

See (EI.SW) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Specialties Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

Symbol	Price	Change %	Market Cap	P/E Ratio	EPS	Dividend Yield
EI.SW	CHF 117.00	+0.00%	88.1B	35.06	CHF 3.34	+1.91%
FRE.SW	CHF 53.05	+0.00%	15.7B	16.21	CHF 3.27	+1.76%
EW.SW	CHF 188.26	N/A	0	N/A	N/A	N/A

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

EI.SW vs FRE.SW Comparison April 2026

EI.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, EI.SW stands at 88.1B. In comparison, FRE.SW has a market cap of 15.7B. Regarding current trading prices, EI.SW is priced at CHF 117.00, while FRE.SW trades at CHF 53.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

EI.SW currently has a P/E ratio of 35.06, whereas FRE.SW's P/E ratio is 16.21. In terms of profitability, EI.SW's ROE is +0.06%, compared to FRE.SW's ROE of +0.04%. Regarding short-term risk, Volatility data is not available for a full comparison. EI.SW has daily volatility of 0.00 and FRE.SW has daily volatility of N/A.Check FRE.SW's competition here